Rutgers and Tel Aviv Universities Joint Scientific Symposia Series: Exploring Drug Discovery

Date & Time

Monday, December 14, 2020, 9:00 a.m.-10:30 a.m.






Event time: 9:00 a.m. EST / 16:00 p.m. IST

Registration details to follow.

Abstract illustration of globe with network connections

Join leading experts from Rutgers and Tel Aviv Universities as they explore the topic of drug discovery.

  • Protein Data Bank: Impact on Drug Discovery and Early Drug Development; Presented by Stephen Burley, MD, DPhil, Rutgers University
Photo of Stephen Burley in front of a large metal collagen structure

Stephen Kevin Burley is an expert in structural biology, biophysics, computational biology, data science, structure/fragment-based drug discovery, and clinical medicine/oncology. Burley is the director of the RCSB Protein Data Bank ( Within Rutgers, he serves as University Professor and Henry Rutgers Chair, founding director of the Institute for Quantitative Biomedicine, and a member of the Rutgers Cancer Institute of New Jersey, where he co-leads the Cancer Pharmacology Research Program.

  • Turning Multidisciplinary Science into Therapeutic Leads; Presented by Ehud Gazit, PhD, FRSC, FNASc OSSI, Tel Aviv University
Photo of Ehud Gazit
Photo by Noah Shahar

Ehud Gazit is a professor and Endowed Chair at the School of Molecular Cell Biology and Biotechnology, Faculty of Life Sciences and the Department of Materials Science and Engineering, Faculty of Engineering and a member of the Executive Council of Tel Aviv University. He is also a member of Israel National Council for Research and Development. Gazit is also the founding director of the BLAVATNIK CENTER for Drug Development and the Head of the Laura Schwartz-Kipp Institute for Biotechnology.

Presentations will be followed by a Q&A session moderated by Vince Smeraglia, Executive Director of Strategic Alliances, Office for Research, Rutgers University

Symposia series hosted by: 

Logos of Rutgers University and Tel Aviv University